Literature DB >> 15007387

CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors.

Shuang-Yin Han1, Dimitrios Iliopoulos, Teresa Druck, Gulnur Guler, Clinton J Grubbs, Michael Pereira, Zhongqiu Zhang, Ming You, Ronald A Lubet, Louise Y Y Fong, Kay Huebner.   

Abstract

To determine if: (1) 5' CpG island methylation is related to Fhit inactivation; (2) there are tumor or carcinogen-specific methylation patterns, we examined 35 CpG sites in the promoter, exon and intron 1 of the mouse Fhit gene. In primary tumors of lung, urinary bladder and tongue, induced by different carcinogens, 15-35% of sites were methylated, with specific methylation patterns associated with each cancer type, suggesting cancer- or tissue-specific methylation patterns. The methylation patterns were associated with reduced Fhit expression, as determined by immunohistochemical analyses. Methylation of rat Fhit 5' CpGs in mammary adenocarcinomas, detected by methylation specific PCR amplification, also correlated with reduced gene expression. Thus, there was an overall association between promoter/exon 1 methylation and decreased Fhit expression. In contrast, in cancer-derived cell lines 70-95% of the CpG sites were methylated. This is the first detailed study of the relationship between Fhit 5' CpG island methylation and Fhit expression in murine tumors, our main models for preclinical cancer studies, and provides evidence that loss of Fhit expression and methylation are correlated in these mouse models and these models will be useful to examine the complex relationships among gene expression, methylation patterns and organ specificity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007387     DOI: 10.1038/sj.onc.1207526

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Insights into the role of DNA methylation in disease through the use of mouse models.

Authors:  Melissa Conerly; William M Grady
Journal:  Dis Model Mech       Date:  2010 May-Jun       Impact factor: 5.758

2.  Isolation and bioinformatics analysis of differentially methylated genomic fragments in human gastric cancer.

Authors:  Ai-Jun Liao; Qi Su; Xun Wang; Bin Zeng; Wei Shi
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

Review 3.  Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings.

Authors:  Romulo Martin Brena; Tim Hui-Ming Huang; Christoph Plass
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

4.  Gene expression profiling of chemically induced rat bladder tumors.

Authors:  Ruisheng Yao; Yijun Yi; Clinton J Grubbs; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

5.  Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model.

Authors:  Scott C Borinstein; Melissa Conerly; Slavomir Dzieciatkowski; Swati Biswas; M Kay Washington; Patty Trobridge; Steve Henikoff; William M Grady
Journal:  Mol Carcinog       Date:  2010-01       Impact factor: 4.784

6.  Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.

Authors:  Rong-Hua Xu; Liang-Yan Zheng; Dong-Lei He; Jian Tong; Li-Ping Zheng; Wu-Ping Zheng; Jin Meng; Li-Ping Xia; Cong-Jun Wang; Ji-Lin Yi
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

7.  DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.

Authors:  Hon-Yi Lin; Shih-Kai Hung; Moon-Sing Lee; Wen-Yen Chiou; Tze-Ta Huang; Chih-En Tseng; Liang-Yu Shih; Ru-Inn Lin; Jora M J Lin; Yi-Hui Lai; Chia-Bin Chang; Feng-Chun Hsu; Liang-Cheng Chen; Shiang-Jiun Tsai; Yu-Chieh Su; Szu-Chi Li; Hung-Chih Lai; Wen-Lin Hsu; Dai-Wei Liu; Chien-Kuo Tai; Shu-Fen Wu; Michael W Y Chan
Journal:  Oncotarget       Date:  2015-01-20

Review 8.  The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review.

Authors:  Wei Yan; Ning Xu; Xiang Han; Xiao-Ming Zhou; Bei He
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

Review 9.  The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review.

Authors:  Xiaoyu Wu; Guannan Wu; Xuequan Yao; Gang Hou; Feng Jiang
Journal:  Drug Des Devel Ther       Date:  2016-02-15       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.